About
Organization
Our Team
Research & Development
Quality Control
Cost Control
Service
Formulation
API
Intermediate
NewCo
Blogs
Pharmaceutical Market Analysis
Unibest Drug Briefing
Unibest Drug IP Watch
Product
Pipelines in ATC Coding
Human Pharma Intermediates
Human Pharma API
Tool Molecules
Cinchona Alkaloids
Halogen Introduction
Molecular Building Blocks
Roche Esters
Biologics
Excipients
ESG
Partnership
Group Site
Join Us
CONTACT
:
All
Product Name
Product Keyword
Product Model
Product Summary
Product Description
Multi Field Search
:
All
Product Name
Product Keyword
Product Model
Product Summary
Product Description
Multi Field Search
About
Organization
Our Team
Research & Development
Quality Control
Cost Control
Service
Formulation
API
Intermediate
NewCo
Blogs
Pharmaceutical Market Analysis
Unibest Drug Briefing
Unibest Drug IP Watch
Product
Pipelines in ATC Coding
Human Pharma Intermediates
Human Pharma API
Tool Molecules
Cinchona Alkaloids
Halogen Introduction
Molecular Building Blocks
Roche Esters
Biologics
Excipients
ESG
Partnership
Group Site
Join Us
CONTACT
Product
:
All
Product Name
Product Keyword
Product Model
Product Summary
Product Description
Multi Field Search
All Products
Image
Product Name
API Name
Last Drug Patent Expires
Details
Year of start producing
CAS No. 1609394-10-6, Deucravacitinib intermediate
Deucravacitinib
11/7/2033 (Deucravacitinib)
View detail »
2023
EMAIL US
info@unibestcn.com
CALL US
+86-574-27855666
QUICK LINKS
Sitemap
Contact Us
News
Our Partner
ABOUT UNIBEST
Organizations
Our Team
Research & Development
Quality Control
Cost Control
PRODUCTS
Pipelines in ATC Coding
Human Health API
Human Health Intermediates
Excipients
Tool Molecules
Biologics
OUR SERVICE
Formulation
API
Intermediate
NewCo
RESPONSIBILITY
Environment
SEARCH PRODUCT :
:
All
Product Name
Product Keyword
Product Model
Product Summary
Product Description
Multi Field Search
Products are for R&D use only and are not intended for human use. We do not sell to patients.
Copyright©
2024
Unibest Industrial Co., Ltd. All Rights Reserved.